La Jolla Pharmaceutical Company (LJPC): Price and Financial Metrics
La Jolla Pharmaceutical Company (LJPC)
Today's Latest Price: $3.90 USD
Updated Sep 25 4:00pm
Add LJPC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
LJPC Stock Summary
- La Jolla Pharmaceutical Co's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 6.41% of US listed stocks.
- LJPC's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 4.67% of US stocks.
- As for revenue growth, note that LJPC's revenue has grown 48.45% over the past 12 months; that beats the revenue growth of 89.68% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to La Jolla Pharmaceutical Co, a group of peers worth examining would be FPRX, PZG, SLAB, GNTX, and MEIP.
- LJPC's SEC filings can be seen here. And to visit La Jolla Pharmaceutical Co's official web site, go to lajollapharmaceutical.com.
LJPC Stock Price Chart Technical Analysis Charts
LJPC Price/Volume Stats
| Current price | $3.90 | 52-week high | $9.71 |
| Prev. close | $3.83 | 52-week low | $2.30 |
| Day low | $3.77 | Volume | 317,199 |
| Day high | $3.94 | Avg. volume | 791,449 |
| 50-day MA | $4.10 | Dividend yield | N/A |
| 200-day MA | $5.41 | Market Cap | 106.71M |
La Jolla Pharmaceutical Company (LJPC) Company Bio
La Jolla Pharmaceutical is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for the treatment of serious bacterial infections and rare genetic disorders, such as cystic fibrosis and Duchenne muscular dystrophy. The company was founded in 1989 and is based in San Diego, California.
Loading social stream, please wait...